GE HealthCare Technologies Inc. which can be found using ticker (GEHC) have now 10 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between $97.00 and $72.00 and has a mean target at $84.60. Given that the stocks previous close was at $73.33 and the analysts are correct then we can expect a percentage increase in value of 15.4%. It’s also worth noting that there is a 50 day moving average of $67.60 while the 200 day moving average is $74.50. The market capitalization for the company is 33.41B. The stock price for the company is currently is currently $73.38 USD
The potential market cap would be $38,539,817,633 based on the market consensus.
The company has a dividend yield of 0.77%. Other points of data to note are a P/E ratio of 21.77, revenue per share of $42.36 and a 6.17% return on assets.
GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics, and digital solutions company. The Company develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. The Company’s segments include Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The Imaging segment includes scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment includes screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment includes medical devices, services, consumable products, services, and digital solutions. The Pharmaceutical Diagnostics segment is a supplier of diagnostic agents to the global radiology and nuclear medicine industry.
